Brynn B. Duncan - Concepedia

Author

Brynn B. Duncan

National Cancer Institute ORCID

Also Known As

B Duncan, B. Duncan, Brynn B Duncan, Brynn B. Duncan, Brynn Duncan, Duncan B, Duncan, B.

Publications

455

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute Center for Cancer Research National Institutes of Health Université de Montréal Tufts University

About

Brynn B. Duncan is an author at National Cancer Institute specializing in immunology, immunotherapy, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	95
2	Immunology	3	3	95
3	Cell Biology	2	2	81
4	Allergy	1	1	28
5	Autoimmune Disease	1	1	28

Brynn B. Duncan

Publications

209

Citations

H-Index

Page 1

	Year	Citations
Val-BoroPro Accelerates T Cell Priming via Modulation of Dendritic Cell Trafficking Resulting in Complete Regression of Established Murine Tumors Meghaan P. Walsh, Brynn B. Duncan, Shannon M. Larabee, PLoS ONE Dendritic Cell VaccinationEstablished Murine TumorsCancer ImmunosurveillanceDendritic Cell VaccinesImmunology	2013	53
Hepatitis in Used Syringes: The Limits of Sensitivity of Techniques to Detect Hepatitis B Virus (HBV) DNA, Hepatitis C Virus (HCV) RNA, and Antibodies to HBV Core and HCV Antigens Robert Heimer, Kaveh Khoshnood, B Jariwala-Freeman, The Journal of Infectious Diseases	1996	38
Murine pre–B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor Haiying Qin, Kazusa Ishii, Sang M. Nguyen, Blood	2018	33
Human Ig production and isotype switching in severe combined immunodeficient-human mice. Bart Vandekerckhove, Derek D. Jones, Juha Punnonen, The Journal of Immunology HistocompatibilityTransgenic Mouse ModelsImmunologyImmunotherapyImmunogenetics	1993	28
A Pan-Inhibitor of DASH Family Enzymes Induces Immune-mediated Regression of Murine Sarcoma and Is a Potent Adjuvant to Dendritic Cell Vaccination and Adoptive T-cell Therapy Brynn B. Duncan, Steven L. Highfill, Haiying Qin, Journal of Immunotherapy	2013	17
Graft-versus-Host Disease Impairs Vaccine Responses through Decreased CD4+ and CD8+ T Cell Proliferation and Increased Perforin-Mediated CD8+ T Cell Apoptosis Christian M. Capitini, Nicole Nasholm, Brynn B. Duncan, The Journal of Immunology	2012	15
A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines Renee N. Donahue, Brynn B. Duncan, Terry J. Fry, Vaccine Cancer ImmunosurveillanceDash Family EnzymesPan InhibitorImmunologyImmunoediting	2014	14
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one Andreas Lundqvist, Vincent van Hoef, Xiaonan Zhang, Journal for ImmunoTherapy of Cancer	2016	11

Page 1